Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
6.72M
-
Number of holders
-
1
-
Total 13F shares, excl. options
-
20K
-
Shares change
-
-8.69M
-
Total reported value, excl. options
-
$904
-
Value change
-
-$597K
-
Number of buys
-
1
-
Number of sells
-
-37
-
Price
-
$0.05
Significant Holders of Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (CDT) as of Q1 2025
38 filings reported holding CDT - Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Conduit Pharmaceuticals Inc. - Common Stock, par value $0.0001 per share (CDT) has 1 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 20K shares
of 6.72M outstanding shares and own 0.3% of the company stock.
Largest 10 shareholders include IFP Advisors, Inc (20K shares), VANGUARD GROUP INC (0 shares), Abel Hall, LLC (0 shares), ProShare Advisors LLC (0 shares), BlackRock, Inc. (0 shares), CITIGROUP INC (0 shares), FMR LLC (0 shares), JPMORGAN CHASE & CO (0 shares), Ameritas Investment Partners, Inc. (0 shares), and SG Americas Securities, LLC (0 shares).
This table shows the top 1 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.